Arronax Nantes > Pre-clinical experimentation and clinical research > Our publications > 2021 > Communication 2021 5
Communication 2021 5
64Cu-ATSM as a therapeutic agent in solid tumor? preliminary results of a whole body human dosimetry study OP-0360.
Varmenot N, Colombié M, Rousseau C, Haddad F, Ferrer L
EANM’21 34th Annual congress of the European Association of Nuclear Medicine, virtual edition, October 20-23 2021